Rapid Assessment of Platelet Function With a Modified Whole-Blood Aggregometer in Percutaneous Transluminal Coronary Angioplasty Patients Receiving Anti-GP IIb/IIIa Therapy
- 2 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (11) , 3860-3866
- https://doi.org/10.1161/01.cir.96.11.3860
Abstract
Background The glycoprotein (GP) IIb/IIIa receptor antagonist abciximab (c7E3 Fab, ReoPro) is approved for use in high-risk percutaneous transluminal coronary angioplasty (PTCA). At present, no “po...Keywords
This publication has 17 references indexed in Scilit:
- Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GPIIb/IIIa receptorsJournal of the American College of Cardiology, 1995
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- A Critical Reappraisal of the Bleeding Time*Seminars in Thrombosis and Hemostasis, 1990
- A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.Journal of Clinical Investigation, 1985
- Binding and inactivation of prostacyclin (PGI2) by human erythrocytesBritish Journal of Haematology, 1983
- Platelet-Activating Factor (PAF-acether): Molecular Aspects of Its Release and Pharmacological ActionsInternational Archives of Allergy and Immunology, 1981
- LEUKOCYTE-DEPENDENT HISTAMINE RELEASE FROM RABBIT PLATELETSThe Journal of Experimental Medicine, 1972
- Heterogeneity of human PlateletsJournal of Clinical Investigation, 1969
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962
- Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood PlateletsNature, 1961